Meagan Whisenant, S. Weathers, Yisheng Li, Ellen Aldrich, Kristin Ownby, Jessica Thomas, An T Ngo-Huang, Eduardo Bruera, K. Milbury
{"title":"Simulation-Based Caregiving Skills Training for Family Members of High-Grade Glioma Patients","authors":"Meagan Whisenant, S. Weathers, Yisheng Li, Ellen Aldrich, Kristin Ownby, Jessica Thomas, An T Ngo-Huang, Eduardo Bruera, K. Milbury","doi":"10.1093/nop/npae025","DOIUrl":null,"url":null,"abstract":"\n \n \n Because family caregivers of patients with a high-grade glioma experience high levels of distress and feel unprepared in performing the complex caregiving tasks associated with the disease and its treatment, we pilot-tested a caregiving skills intervention that integrates hands-on caregiving with coping skill training.\n \n \n \n In this single-arm trial, caregivers participated in a 4-session research nurse-led intervention involving simulation-based caregiving skills training at the hospital and psychoeducation delivered via videoconference. We collected measures of patients’ and caregivers’ psychological symptoms (HADS); caregivers’ caregiving self-efficacy (CSE) and role adjustment (CRA); and patient’s cancer-related symptoms (MDASI) at baseline and again post-intervention. We tracked feasibility data.\n \n \n \n We approached 29 dyads of which 10 dyads (34%) consented. All patients (mean age: 60 years, 89% male) and caregivers (mean age: 58 years, 80% female, 80% spouses) completed the baseline and 7 dyads completed the follow-up assessments (attrition was related to patient’s hospice transfer). Seven caregivers completed all 4 sessions and rated the program as beneficial. Paired t-tests revealed a significant improvement in caregiving self-efficacy at 6 weeks post-intervention (t =-3.06, P=.02). Although improvements in caregiver role adjustment and patient and caregiver symptoms were not observed, no decreases in symptom burden or role adjustment were found during the follow-up period.\n \n \n \n This novel supportive care program appears to be safe, feasible, acceptable, and perceived as useful for caregivers of patients with high-grade glioma. Based on feasibility indicators and a signal of intervention efficacy, a randomized controlled trial is warranted.\n","PeriodicalId":506567,"journal":{"name":"Neuro-Oncology Practice","volume":" 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-Oncology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Because family caregivers of patients with a high-grade glioma experience high levels of distress and feel unprepared in performing the complex caregiving tasks associated with the disease and its treatment, we pilot-tested a caregiving skills intervention that integrates hands-on caregiving with coping skill training.
In this single-arm trial, caregivers participated in a 4-session research nurse-led intervention involving simulation-based caregiving skills training at the hospital and psychoeducation delivered via videoconference. We collected measures of patients’ and caregivers’ psychological symptoms (HADS); caregivers’ caregiving self-efficacy (CSE) and role adjustment (CRA); and patient’s cancer-related symptoms (MDASI) at baseline and again post-intervention. We tracked feasibility data.
We approached 29 dyads of which 10 dyads (34%) consented. All patients (mean age: 60 years, 89% male) and caregivers (mean age: 58 years, 80% female, 80% spouses) completed the baseline and 7 dyads completed the follow-up assessments (attrition was related to patient’s hospice transfer). Seven caregivers completed all 4 sessions and rated the program as beneficial. Paired t-tests revealed a significant improvement in caregiving self-efficacy at 6 weeks post-intervention (t =-3.06, P=.02). Although improvements in caregiver role adjustment and patient and caregiver symptoms were not observed, no decreases in symptom burden or role adjustment were found during the follow-up period.
This novel supportive care program appears to be safe, feasible, acceptable, and perceived as useful for caregivers of patients with high-grade glioma. Based on feasibility indicators and a signal of intervention efficacy, a randomized controlled trial is warranted.